Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -364,831 | -188,386 | -581,784 | -382,164 | -302,110 |
| Depreciation Amortization | 2,779 | 1,611 | 6,483 | 4,722 | 2,930 |
| Other Working Capital | -29,376 | -21,676 | 65,588 | 42,627 | 36,024 |
| Other Operating Activity | 87,467 | 47,982 | 120,913 | 84,000 | 59,373 |
| Operating Cash Flow | $-303,961 | $-160,469 | $-388,800 | $-250,815 | $-203,783 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 496,834 | 50,695 | -579,106 | -410,917 | 352,258 |
| PPE Investments | -2,801 | -1,140 | -9,795 | -7,146 | -5,137 |
| Purchase Of Investment | -341,472 | N/A | N/A | N/A | -765,888 |
| Investing Cash Flow | $152,561 | $49,555 | $-588,901 | $-418,063 | $-418,767 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,919 | 2,527 | 505,222 | 25,940 | 17,708 |
| Financing Cash Flow | $3,919 | $2,527 | $505,222 | $25,940 | $17,708 |
| Beginning Cash Position | 413,703 | 413,703 | 886,182 | 886,182 | 886,182 |
| End Cash Position | 266,222 | 305,316 | 413,703 | 243,244 | 281,340 |
| Net Cash Flow | $-147,481 | $-108,387 | $-472,479 | $-642,938 | $-604,842 |
| Free Cash Flow | |||||
| Operating Cash Flow | -303,961 | -160,469 | -388,800 | -250,815 | -203,783 |
| Capital Expenditure | -2,801 | -1,140 | -9,795 | -7,146 | -5,137 |
| Free Cash Flow | -306,762 | -161,609 | -398,595 | -257,961 | -208,920 |